IsoRay Names Jonathan Hunt New Chief Financial Officer

RICHLAND, WASHINGTON – December 3, 2018 – IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, announced that Jonathan Hunt has been named Chief Financial Officer...
Your one-stop shop for the latest in brachytherapy at ASTRO 2018

Your one-stop shop for the latest in brachytherapy at ASTRO 2018

Between a radiation oncologist’s caseload, administrative responsibilities and personal life, keeping tabs on – or even conducting – new research is a difficult task. Capitalizing on the same value ASTRO provides for radiation oncologists to connect with...
Brachytherapy: An Innovative Disruptor

Brachytherapy: An Innovative Disruptor

Dr. Brian Moran, Medical Director for the Chicago Prostate Center, discusses the value of low-dose rate brachytherapy and its disruptive innovation in the cancer treatment field. Dr. Moran stresses how important it is for clinicians to recognize the value of...